世界の日光（太陽）角化症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Actinic (Solar) Keratosis Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5561
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、107ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、日光（太陽）角化症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（854-A、ACT-01、AD-17137、セレコキシブ、DFD-08、GDC-695、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・日光（太陽）角化症治療の市場動向
・企業の競争状況、市場シェア
・日光（太陽）角化症治療の種類別市場規模と予測2016-2027（854-A、ACT-01、AD-17137、セレコキシブ、DFD-08、GDC-695、その他）
・日光（太陽）角化症治療の用途別市場規模と予測2016-2027（病院、診療所、その他）
・日光（太陽）角化症治療の北米市場規模2016-2027（アメリカ、カナダ）
・日光（太陽）角化症治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・日光（太陽）角化症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・日光（太陽）角化症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・日光（太陽）角化症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（3M Drug Delivery Systems、Athenex Inc、CritiTech Inc、Foamix Pharmaceuticals Ltd、G&E Herbal Biotechnology Co Ltd、Galderma SA、Laboratories Ojer Pharma SL、LEO Pharma A/S、Novartis AG、Oncology Research International Ltd、Promius Pharma LLC、Valeant Pharmaceuticals International Inc、Vectura Group Plc）
・結論

Market Analysis and Insights: Global Actinic (Solar) Keratosis Treatment Market
The global Actinic (Solar) Keratosis Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Actinic (Solar) Keratosis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Actinic (Solar) Keratosis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Actinic (Solar) Keratosis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Actinic (Solar) Keratosis Treatment market.

Global Actinic (Solar) Keratosis Treatment Scope and Market Size
Actinic (Solar) Keratosis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Actinic (Solar) Keratosis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
854-A
ACT-01
AD-17137
Celecoxib
DFD-08
GDC-695
Others

Segment by Application
Hospital
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
3M Drug Delivery Systems
Athenex Inc
CritiTech Inc
Foamix Pharmaceuticals Ltd
G&E Herbal Biotechnology Co Ltd
Galderma SA
Laboratories Ojer Pharma SL
LEO Pharma A/S
Novartis AG
Oncology Research International Ltd
Promius Pharma LLC
Valeant Pharmaceuticals International Inc
Vectura Group Plc

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Actinic (Solar) Keratosis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 854-A
1.2.3 ACT-01
1.2.4 AD-17137
1.2.5 Celecoxib
1.2.6 DFD-08
1.2.7 GDC-695
1.2.8 Others
1.3 Market by Application
1.3.1 Global Actinic (Solar) Keratosis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Actinic (Solar) Keratosis Treatment Market Perspective (2016-2027)
2.2 Actinic (Solar) Keratosis Treatment Growth Trends by Regions
2.2.1 Actinic (Solar) Keratosis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Actinic (Solar) Keratosis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Actinic (Solar) Keratosis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Actinic (Solar) Keratosis Treatment Industry Dynamic
2.3.1 Actinic (Solar) Keratosis Treatment Market Trends
2.3.2 Actinic (Solar) Keratosis Treatment Market Drivers
2.3.3 Actinic (Solar) Keratosis Treatment Market Challenges
2.3.4 Actinic (Solar) Keratosis Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Actinic (Solar) Keratosis Treatment Players by Revenue
3.1.1 Global Top Actinic (Solar) Keratosis Treatment Players by Revenue (2016-2021)
3.1.2 Global Actinic (Solar) Keratosis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Actinic (Solar) Keratosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Actinic (Solar) Keratosis Treatment Revenue
3.4 Global Actinic (Solar) Keratosis Treatment Market Concentration Ratio
3.4.1 Global Actinic (Solar) Keratosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Actinic (Solar) Keratosis Treatment Revenue in 2020
3.5 Actinic (Solar) Keratosis Treatment Key Players Head office and Area Served
3.6 Key Players Actinic (Solar) Keratosis Treatment Product Solution and Service
3.7 Date of Enter into Actinic (Solar) Keratosis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Actinic (Solar) Keratosis Treatment Breakdown Data by Type
4.1 Global Actinic (Solar) Keratosis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Actinic (Solar) Keratosis Treatment Forecasted Market Size by Type (2022-2027)

5 Actinic (Solar) Keratosis Treatment Breakdown Data by Application
5.1 Global Actinic (Solar) Keratosis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Actinic (Solar) Keratosis Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Actinic (Solar) Keratosis Treatment Market Size (2016-2027)
6.2 North America Actinic (Solar) Keratosis Treatment Market Size by Type
6.2.1 North America Actinic (Solar) Keratosis Treatment Market Size by Type (2016-2021)
6.2.2 North America Actinic (Solar) Keratosis Treatment Market Size by Type (2022-2027)
6.2.3 North America Actinic (Solar) Keratosis Treatment Market Size by Type (2016-2027)
6.3 North America Actinic (Solar) Keratosis Treatment Market Size by Application
6.3.1 North America Actinic (Solar) Keratosis Treatment Market Size by Application (2016-2021)
6.3.2 North America Actinic (Solar) Keratosis Treatment Market Size by Application (2022-2027)
6.3.3 North America Actinic (Solar) Keratosis Treatment Market Size by Application (2016-2027)
6.4 North America Actinic (Solar) Keratosis Treatment Market Size by Country
6.4.1 North America Actinic (Solar) Keratosis Treatment Market Size by Country (2016-2021)
6.4.2 North America Actinic (Solar) Keratosis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Actinic (Solar) Keratosis Treatment Market Size (2016-2027)
7.2 Europe Actinic (Solar) Keratosis Treatment Market Size by Type
7.2.1 Europe Actinic (Solar) Keratosis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Actinic (Solar) Keratosis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Actinic (Solar) Keratosis Treatment Market Size by Type (2016-2027)
7.3 Europe Actinic (Solar) Keratosis Treatment Market Size by Application
7.3.1 Europe Actinic (Solar) Keratosis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Actinic (Solar) Keratosis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Actinic (Solar) Keratosis Treatment Market Size by Application (2016-2027)
7.4 Europe Actinic (Solar) Keratosis Treatment Market Size by Country
7.4.1 Europe Actinic (Solar) Keratosis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Actinic (Solar) Keratosis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Actinic (Solar) Keratosis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Actinic (Solar) Keratosis Treatment Market Size by Type
8.2.1 Asia-Pacific Actinic (Solar) Keratosis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Actinic (Solar) Keratosis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Actinic (Solar) Keratosis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Actinic (Solar) Keratosis Treatment Market Size by Application
8.3.1 Asia-Pacific Actinic (Solar) Keratosis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Actinic (Solar) Keratosis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Actinic (Solar) Keratosis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Actinic (Solar) Keratosis Treatment Market Size by Region
8.4.1 Asia-Pacific Actinic (Solar) Keratosis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Actinic (Solar) Keratosis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Actinic (Solar) Keratosis Treatment Market Size (2016-2027)
9.2 Latin America Actinic (Solar) Keratosis Treatment Market Size by Type
9.2.1 Latin America Actinic (Solar) Keratosis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Actinic (Solar) Keratosis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Actinic (Solar) Keratosis Treatment Market Size by Type (2016-2027)
9.3 Latin America Actinic (Solar) Keratosis Treatment Market Size by Application
9.3.1 Latin America Actinic (Solar) Keratosis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Actinic (Solar) Keratosis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Actinic (Solar) Keratosis Treatment Market Size by Application (2016-2027)
9.4 Latin America Actinic (Solar) Keratosis Treatment Market Size by Country
9.4.1 Latin America Actinic (Solar) Keratosis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Actinic (Solar) Keratosis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Actinic (Solar) Keratosis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Actinic (Solar) Keratosis Treatment Market Size by Type
10.2.1 Middle East & Africa Actinic (Solar) Keratosis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Actinic (Solar) Keratosis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Actinic (Solar) Keratosis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Actinic (Solar) Keratosis Treatment Market Size by Application
10.3.1 Middle East & Africa Actinic (Solar) Keratosis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Actinic (Solar) Keratosis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Actinic (Solar) Keratosis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Actinic (Solar) Keratosis Treatment Market Size by Country
10.4.1 Middle East & Africa Actinic (Solar) Keratosis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Actinic (Solar) Keratosis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 3M Drug Delivery Systems
11.1.1 3M Drug Delivery Systems Company Details
11.1.2 3M Drug Delivery Systems Business Overview
11.1.3 3M Drug Delivery Systems Actinic (Solar) Keratosis Treatment Introduction
11.1.4 3M Drug Delivery Systems Revenue in Actinic (Solar) Keratosis Treatment Business (2016-2021)
11.1.5 3M Drug Delivery Systems Recent Development
11.2 Athenex Inc
11.2.1 Athenex Inc Company Details
11.2.2 Athenex Inc Business Overview
11.2.3 Athenex Inc Actinic (Solar) Keratosis Treatment Introduction
11.2.4 Athenex Inc Revenue in Actinic (Solar) Keratosis Treatment Business (2016-2021)
11.2.5 Athenex Inc Recent Development
11.3 CritiTech Inc
11.3.1 CritiTech Inc Company Details
11.3.2 CritiTech Inc Business Overview
11.3.3 CritiTech Inc Actinic (Solar) Keratosis Treatment Introduction
11.3.4 CritiTech Inc Revenue in Actinic (Solar) Keratosis Treatment Business (2016-2021)
11.3.5 CritiTech Inc Recent Development
11.4 Foamix Pharmaceuticals Ltd
11.4.1 Foamix Pharmaceuticals Ltd Company Details
11.4.2 Foamix Pharmaceuticals Ltd Business Overview
11.4.3 Foamix Pharmaceuticals Ltd Actinic (Solar) Keratosis Treatment Introduction
11.4.4 Foamix Pharmaceuticals Ltd Revenue in Actinic (Solar) Keratosis Treatment Business (2016-2021)
11.4.5 Foamix Pharmaceuticals Ltd Recent Development
11.5 G&E Herbal Biotechnology Co Ltd
11.5.1 G&E Herbal Biotechnology Co Ltd Company Details
11.5.2 G&E Herbal Biotechnology Co Ltd Business Overview
11.5.3 G&E Herbal Biotechnology Co Ltd Actinic (Solar) Keratosis Treatment Introduction
11.5.4 G&E Herbal Biotechnology Co Ltd Revenue in Actinic (Solar) Keratosis Treatment Business (2016-2021)
11.5.5 G&E Herbal Biotechnology Co Ltd Recent Development
11.6 Galderma SA
11.6.1 Galderma SA Company Details
11.6.2 Galderma SA Business Overview
11.6.3 Galderma SA Actinic (Solar) Keratosis Treatment Introduction
11.6.4 Galderma SA Revenue in Actinic (Solar) Keratosis Treatment Business (2016-2021)
11.6.5 Galderma SA Recent Development
11.7 Laboratories Ojer Pharma SL
11.7.1 Laboratories Ojer Pharma SL Company Details
11.7.2 Laboratories Ojer Pharma SL Business Overview
11.7.3 Laboratories Ojer Pharma SL Actinic (Solar) Keratosis Treatment Introduction
11.7.4 Laboratories Ojer Pharma SL Revenue in Actinic (Solar) Keratosis Treatment Business (2016-2021)
11.7.5 Laboratories Ojer Pharma SL Recent Development
11.8 LEO Pharma A/S
11.8.1 LEO Pharma A/S Company Details
11.8.2 LEO Pharma A/S Business Overview
11.8.3 LEO Pharma A/S Actinic (Solar) Keratosis Treatment Introduction
11.8.4 LEO Pharma A/S Revenue in Actinic (Solar) Keratosis Treatment Business (2016-2021)
11.8.5 LEO Pharma A/S Recent Development
11.9 Novartis AG
11.9.1 Novartis AG Company Details
11.9.2 Novartis AG Business Overview
11.9.3 Novartis AG Actinic (Solar) Keratosis Treatment Introduction
11.9.4 Novartis AG Revenue in Actinic (Solar) Keratosis Treatment Business (2016-2021)
11.9.5 Novartis AG Recent Development
11.10 Oncology Research International Ltd
11.10.1 Oncology Research International Ltd Company Details
11.10.2 Oncology Research International Ltd Business Overview
11.10.3 Oncology Research International Ltd Actinic (Solar) Keratosis Treatment Introduction
11.10.4 Oncology Research International Ltd Revenue in Actinic (Solar) Keratosis Treatment Business (2016-2021)
11.10.5 Oncology Research International Ltd Recent Development
11.11 Promius Pharma LLC
11.11.1 Promius Pharma LLC Company Details
11.11.2 Promius Pharma LLC Business Overview
11.11.3 Promius Pharma LLC Actinic (Solar) Keratosis Treatment Introduction
11.11.4 Promius Pharma LLC Revenue in Actinic (Solar) Keratosis Treatment Business (2016-2021)
11.11.5 Promius Pharma LLC Recent Development
11.12 Valeant Pharmaceuticals International Inc
11.12.1 Valeant Pharmaceuticals International Inc Company Details
11.12.2 Valeant Pharmaceuticals International Inc Business Overview
11.12.3 Valeant Pharmaceuticals International Inc Actinic (Solar) Keratosis Treatment Introduction
11.12.4 Valeant Pharmaceuticals International Inc Revenue in Actinic (Solar) Keratosis Treatment Business (2016-2021)
11.12.5 Valeant Pharmaceuticals International Inc Recent Development
11.13 Vectura Group Plc
11.13.1 Vectura Group Plc Company Details
11.13.2 Vectura Group Plc Business Overview
11.13.3 Vectura Group Plc Actinic (Solar) Keratosis Treatment Introduction
11.13.4 Vectura Group Plc Revenue in Actinic (Solar) Keratosis Treatment Business (2016-2021)
11.13.5 Vectura Group Plc Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Actinic (Solar) Keratosis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of 854-A
Table 3. Key Players of ACT-01
Table 4. Key Players of AD-17137
Table 5. Key Players of Celecoxib
Table 6. Key Players of DFD-08
Table 7. Key Players of GDC-695
Table 8. Key Players of Others
Table 9. Global Actinic (Solar) Keratosis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Actinic (Solar) Keratosis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Actinic (Solar) Keratosis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Actinic (Solar) Keratosis Treatment Market Share by Regions (2016-2021)
Table 13. Global Actinic (Solar) Keratosis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Actinic (Solar) Keratosis Treatment Market Share by Regions (2022-2027)
Table 15. Actinic (Solar) Keratosis Treatment Market Trends
Table 16. Actinic (Solar) Keratosis Treatment Market Drivers
Table 17. Actinic (Solar) Keratosis Treatment Market Challenges
Table 18. Actinic (Solar) Keratosis Treatment Market Restraints
Table 19. Global Actinic (Solar) Keratosis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Actinic (Solar) Keratosis Treatment Market Share by Players (2016-2021)
Table 21. Global Top Actinic (Solar) Keratosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Actinic (Solar) Keratosis Treatment as of 2020)
Table 22. Ranking of Global Top Actinic (Solar) Keratosis Treatment Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Actinic (Solar) Keratosis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Actinic (Solar) Keratosis Treatment Product Solution and Service
Table 26. Date of Enter into Actinic (Solar) Keratosis Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Actinic (Solar) Keratosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Actinic (Solar) Keratosis Treatment Revenue Market Share by Type (2016-2021)
Table 30. Global Actinic (Solar) Keratosis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Actinic (Solar) Keratosis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Actinic (Solar) Keratosis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Actinic (Solar) Keratosis Treatment Revenue Market Share by Application (2016-2021)
Table 34. Global Actinic (Solar) Keratosis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Actinic (Solar) Keratosis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Actinic (Solar) Keratosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Actinic (Solar) Keratosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Actinic (Solar) Keratosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Actinic (Solar) Keratosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Actinic (Solar) Keratosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Actinic (Solar) Keratosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Actinic (Solar) Keratosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Actinic (Solar) Keratosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Actinic (Solar) Keratosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Actinic (Solar) Keratosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Actinic (Solar) Keratosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Actinic (Solar) Keratosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Actinic (Solar) Keratosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Actinic (Solar) Keratosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Actinic (Solar) Keratosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Actinic (Solar) Keratosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Actinic (Solar) Keratosis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Actinic (Solar) Keratosis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Actinic (Solar) Keratosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Actinic (Solar) Keratosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Actinic (Solar) Keratosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Actinic (Solar) Keratosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Actinic (Solar) Keratosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Actinic (Solar) Keratosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Actinic (Solar) Keratosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Actinic (Solar) Keratosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Actinic (Solar) Keratosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Actinic (Solar) Keratosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Actinic (Solar) Keratosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Actinic (Solar) Keratosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 66. 3M Drug Delivery Systems Company Details
Table 67. 3M Drug Delivery Systems Business Overview
Table 68. 3M Drug Delivery Systems Actinic (Solar) Keratosis Treatment Product
Table 69. 3M Drug Delivery Systems Revenue in Actinic (Solar) Keratosis Treatment Business (2016-2021) & (US$ Million)
Table 70. 3M Drug Delivery Systems Recent Development
Table 71. Athenex Inc Company Details
Table 72. Athenex Inc Business Overview
Table 73. Athenex Inc Actinic (Solar) Keratosis Treatment Product
Table 74. Athenex Inc Revenue in Actinic (Solar) Keratosis Treatment Business (2016-2021) & (US$ Million)
Table 75. Athenex Inc Recent Development
Table 76. CritiTech Inc Company Details
Table 77. CritiTech Inc Business Overview
Table 78. CritiTech Inc Actinic (Solar) Keratosis Treatment Product
Table 79. CritiTech Inc Revenue in Actinic (Solar) Keratosis Treatment Business (2016-2021) & (US$ Million)
Table 80. CritiTech Inc Recent Development
Table 81. Foamix Pharmaceuticals Ltd Company Details
Table 82. Foamix Pharmaceuticals Ltd Business Overview
Table 83. Foamix Pharmaceuticals Ltd Actinic (Solar) Keratosis Treatment Product
Table 84. Foamix Pharmaceuticals Ltd Revenue in Actinic (Solar) Keratosis Treatment Business (2016-2021) & (US$ Million)
Table 85. Foamix Pharmaceuticals Ltd Recent Development
Table 86. G&E Herbal Biotechnology Co Ltd Company Details
Table 87. G&E Herbal Biotechnology Co Ltd Business Overview
Table 88. G&E Herbal Biotechnology Co Ltd Actinic (Solar) Keratosis Treatment Product
Table 89. G&E Herbal Biotechnology Co Ltd Revenue in Actinic (Solar) Keratosis Treatment Business (2016-2021) & (US$ Million)
Table 90. G&E Herbal Biotechnology Co Ltd Recent Development
Table 91. Galderma SA Company Details
Table 92. Galderma SA Business Overview
Table 93. Galderma SA Actinic (Solar) Keratosis Treatment Product
Table 94. Galderma SA Revenue in Actinic (Solar) Keratosis Treatment Business (2016-2021) & (US$ Million)
Table 95. Galderma SA Recent Development
Table 96. Laboratories Ojer Pharma SL Company Details
Table 97. Laboratories Ojer Pharma SL Business Overview
Table 98. Laboratories Ojer Pharma SL Actinic (Solar) Keratosis Treatment Product
Table 99. Laboratories Ojer Pharma SL Revenue in Actinic (Solar) Keratosis Treatment Business (2016-2021) & (US$ Million)
Table 100. Laboratories Ojer Pharma SL Recent Development
Table 101. LEO Pharma A/S Company Details
Table 102. LEO Pharma A/S Business Overview
Table 103. LEO Pharma A/S Revenue in Actinic (Solar) Keratosis Treatment Business (2016-2021) & (US$ Million)
Table 104. LEO Pharma A/S Recent Development
Table 105. Novartis AG Company Details
Table 106. Novartis AG Business Overview
Table 107. Novartis AG Actinic (Solar) Keratosis Treatment Product
Table 108. Novartis AG Revenue in Actinic (Solar) Keratosis Treatment Business (2016-2021) & (US$ Million)
Table 109. Novartis AG Recent Development
Table 110. Oncology Research International Ltd Company Details
Table 111. Oncology Research International Ltd Business Overview
Table 112. Oncology Research International Ltd Actinic (Solar) Keratosis Treatment Product
Table 113. Oncology Research International Ltd Revenue in Actinic (Solar) Keratosis Treatment Business (2016-2021) & (US$ Million)
Table 114. Oncology Research International Ltd Recent Development
Table 115. Promius Pharma LLC Company Details
Table 116. Promius Pharma LLC Business Overview
Table 117. Promius Pharma LLC Actinic (Solar) Keratosis Treatment Product
Table 118. Promius Pharma LLC Revenue in Actinic (Solar) Keratosis Treatment Business (2016-2021) & (US$ Million)
Table 119. Promius Pharma LLC Recent Development
Table 120. Valeant Pharmaceuticals International Inc Company Details
Table 121. Valeant Pharmaceuticals International Inc Business Overview
Table 122. Valeant Pharmaceuticals International Inc Actinic (Solar) Keratosis Treatment Product
Table 123. Valeant Pharmaceuticals International Inc Revenue in Actinic (Solar) Keratosis Treatment Business (2016-2021) & (US$ Million)
Table 124. Valeant Pharmaceuticals International Inc Recent Development
Table 125. Vectura Group Plc Company Details
Table 126. Vectura Group Plc Business Overview
Table 127. Vectura Group Plc Actinic (Solar) Keratosis Treatment Product
Table 128. Vectura Group Plc Revenue in Actinic (Solar) Keratosis Treatment Business (2016-2021) & (US$ Million)
Table 129. Vectura Group Plc Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Actinic (Solar) Keratosis Treatment Market Share by Type: 2020 VS 2027
Figure 2. 854-A Features
Figure 3. ACT-01 Features
Figure 4. AD-17137 Features
Figure 5. Celecoxib Features
Figure 6. DFD-08 Features
Figure 7. GDC-695 Features
Figure 8. Others Features
Figure 9. Global Actinic (Solar) Keratosis Treatment Market Share by Application: 2020 VS 2027
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Others Case Studies
Figure 13. Actinic (Solar) Keratosis Treatment Report Years Considered
Figure 14. Global Actinic (Solar) Keratosis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Actinic (Solar) Keratosis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Actinic (Solar) Keratosis Treatment Market Share by Regions: 2020 VS 2027
Figure 17. Global Actinic (Solar) Keratosis Treatment Market Share by Regions (2022-2027)
Figure 18. Global Actinic (Solar) Keratosis Treatment Market Share by Players in 2020
Figure 19. Global Top Actinic (Solar) Keratosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Actinic (Solar) Keratosis Treatment as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Actinic (Solar) Keratosis Treatment Revenue in 2020
Figure 21. Global Actinic (Solar) Keratosis Treatment Revenue Market Share by Type (2016-2021)
Figure 22. Global Actinic (Solar) Keratosis Treatment Revenue Market Share by Type (2022-2027)
Figure 23. North America Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Actinic (Solar) Keratosis Treatment Market Share by Type (2016-2027)
Figure 25. North America Actinic (Solar) Keratosis Treatment Market Share by Application (2016-2027)
Figure 26. North America Actinic (Solar) Keratosis Treatment Market Share by Country (2016-2027)
Figure 27. United States Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Actinic (Solar) Keratosis Treatment Market Share by Type (2016-2027)
Figure 31. Europe Actinic (Solar) Keratosis Treatment Market Share by Application (2016-2027)
Figure 32. Europe Actinic (Solar) Keratosis Treatment Market Share by Country (2016-2027)
Figure 33. Germany Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Actinic (Solar) Keratosis Treatment Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Actinic (Solar) Keratosis Treatment Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Actinic (Solar) Keratosis Treatment Market Share by Region (2016-2027)
Figure 43. China Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Actinic (Solar) Keratosis Treatment Market Share by Type (2016-2027)
Figure 51. Latin America Actinic (Solar) Keratosis Treatment Market Share by Application (2016-2027)
Figure 52. Latin America Actinic (Solar) Keratosis Treatment Market Share by Country (2016-2027)
Figure 53. Mexico Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Actinic (Solar) Keratosis Treatment Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Actinic (Solar) Keratosis Treatment Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Actinic (Solar) Keratosis Treatment Market Share by Country (2016-2027)
Figure 59. Turkey Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Actinic (Solar) Keratosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. 3M Drug Delivery Systems Revenue Growth Rate in Actinic (Solar) Keratosis Treatment Business (2016-2021)
Figure 63. Athenex Inc Revenue Growth Rate in Actinic (Solar) Keratosis Treatment Business (2016-2021)
Figure 64. CritiTech Inc Revenue Growth Rate in Actinic (Solar) Keratosis Treatment Business (2016-2021)
Figure 65. Foamix Pharmaceuticals Ltd Revenue Growth Rate in Actinic (Solar) Keratosis Treatment Business (2016-2021)
Figure 66. G&E Herbal Biotechnology Co Ltd Revenue Growth Rate in Actinic (Solar) Keratosis Treatment Business (2016-2021)
Figure 67. Galderma SA Revenue Growth Rate in Actinic (Solar) Keratosis Treatment Business (2016-2021)
Figure 68. Laboratories Ojer Pharma SL Revenue Growth Rate in Actinic (Solar) Keratosis Treatment Business (2016-2021)
Figure 69. LEO Pharma A/S Revenue Growth Rate in Actinic (Solar) Keratosis Treatment Business (2016-2021)
Figure 70. Novartis AG Revenue Growth Rate in Actinic (Solar) Keratosis Treatment Business (2016-2021)
Figure 71. Oncology Research International Ltd Revenue Growth Rate in Actinic (Solar) Keratosis Treatment Business (2016-2021)
Figure 72. Promius Pharma LLC Revenue Growth Rate in Actinic (Solar) Keratosis Treatment Business (2016-2021)
Figure 73. Valeant Pharmaceuticals International Inc Revenue Growth Rate in Actinic (Solar) Keratosis Treatment Business (2016-2021)
Figure 74. Vectura Group Plc Revenue Growth Rate in Actinic (Solar) Keratosis Treatment Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed

以下、関連資料のご紹介

光線性(日光性)角化症治療のグローバル市場調査 2019年

Global Actinic (Solar) Keratosis Treatment Market Professional Survey Report 2019
QYR9NV00121 2019年11月12日 115Pages
※本調査レポートは、光線性(日光性)角化症治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、854-A、ACT-01、AD-17137、セレコキシブ、DFD...

世界の毛孔性角化症治療市場規模・現状・予測（2021年-2027年）

Global Keratosis Pilaris Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5817 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、毛孔性角化症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ローション、ボディスクラブ、ボディウォッシュ＆シャワージェル、その他）、用途別市場規模（ボディ用、フェイシャルスキン用）、主要地域別市場...

世界の日光角化症治療市場規模・現状・予測（2021年-2027年）

Global Solar Keratoses Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6016 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、日光角化症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（外用薬、光線力学療法、破壊的治療）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中...

世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3803 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界のOAB治療市場規模・現状・予測（2021年-2027年）

Global OAB Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5902 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、OAB治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗コリン作用薬、ミラベグロン、ボトックス）、用途別市場規模（特発性過活動膀胱、神経性過活動膀胱）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の色汗症治療市場規模・現状・予測（2021年-2027年）

Global Chromhidrosis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5658 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、色汗症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アポクリン色汗症、エクリン色汗症、偽色汗症）、用途別市場規模（病院＆診療所、専門医＆皮膚科医院、その他）、主要地域別市場規模（北米、アメリカ、...

世界の総胆管結石症治療市場規模・現状・予測（2021年-2027年）

Global Choledocholithiasis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4004 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、総胆管結石症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、外科的治療）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界の天然痘治療市場規模・現状・予測（2021年-2027年）

Global Smallpox Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6015 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、天然痘治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、ワクチン）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界の肝腎症候群治療市場規模・現状・予測（2021年-2027年）

Global Hepatorenal Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4305 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、肝腎症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ヘパトレン、テルリバズ、グリプレシン、ルカシン、その他）、用途別市場規模（1型肝腎症候群、2型肝腎症候群）、主要地域別市場規模（北米、アメ...

世界の痙性斜頸治療市場規模・現状・予測（2021年-2027年）

Global Cervical Dystonia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5653 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、痙性斜頸治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ボツリヌス菌、抗コリン作用薬、ドーパミン作動薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模（...

光線性(日光性)角化症治療のグローバル市場調査 2019年 The global Actinic (Solar) Keratosis Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Actinic (Solar) Keratosis Treatment volume and value at global level, regional level and company level.…
世界の毛孔性角化症治療市場規模・現状・予測（2021年-2027年） Keratosis pilaris is a common, harmless skin condition. It causes small, hard bumps that may make your skin feel like sandpaper.The bumps are often light-colored. They usually appear on your upper arms, thighs, and buttocks, sometimes with redness or swelling. They can also show up on your face, but…
世界の日光角化症治療市場規模・現状・予測（2021年-2027年） Solar keratoses are keratotic macules, papules, or plaques resulting from the intraepidermal proliferation of atypical keratinocytes in response to prolonged exposure to ultraviolet radiation. It's most commonly found on the face, lips, ears, back of your hands, forearms, scalp or neck. Market Analy…
世界の非薬物式うつ病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Drug Free Depression Treatment Market The global Drug Free Depression Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data int…
世界のセレコキシブカプセル市場規模・現状・予測（2021年-2027年） Celecoxib, sold under the brand name Celebrex among others, is a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). It is used to treat the pain and inflammation in osteoarthritis, acute pain in adults, rheumatoid arthritis, ankylosing spondylitis, painful menstruation, and juvenile rheuma…